Srikanth Vallurupalli

High Impact

Associate Professor

UAMS primary UA Little Rock University of Arkansas

Also affiliated: Southern Illinois University Carbondale (2011); Rush University Medical Center (2024); MedStar Washington Hospital Center (2013); University of Kentucky (1995–2018); University of Miami (2013); University of Kansas (2013); Emory University (2013); University of Illinois Urbana-Champaign (2007–2009); Wayne State University (2013); SIU Medicine (2009–2011); University of Arkansas Medical Center (2015–2026); Truman Medical Center (2022); Staten Island University Hospital (2013); Washington Hospital (2013); Henry Ford Hospital (2021); Central Arkansas Veterans Healthcare System (2014–2026); Minneapolis Heart Institute Foundation (2018); Association Clinique et Thérapeutique Infantile du Val de Marne (2023); Novant Health Forsyth Medical Center (2024); Drexel University (2013); University of Missouri–Kansas City (2021–2022); The University of Texas Health Science Center at Houston (2026)

Internal Med, College of Medicine

22 h-index 226 pubs 2,618 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Srikanth Vallurupalli's research focuses on cardiovascular diseases, with a particular emphasis on treatment outcomes and risk factors. He has investigated the efficacy and safety of various pharmacological interventions, including sodium-glucose cotransporter 2 inhibitors for patients with acute heart failure and those with and without type 2 diabetes. His work also extends to understanding the impact of specific patient characteristics, such as hepatitis C seropositivity, on the risk of coronary heart disease events.

Vallurupalli's research portfolio includes studies on in-hospital complications associated with medical procedures, such as catheter ablation of atrial fibrillation. He has also contributed to the understanding and management of left ventricular thrombus, publishing on both challenges in management and scientific statements from the American Heart Association. His scholarly metrics include an h-index of 22, over 219 total publications, and approximately 2,600 citations, reflecting his productivity and impact in the field. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Fuad Habash, Hakan Paydak, Subodh Devabhaktuni, and Barry F. Uretsky.

Research Overview

Srikanth Vallurupalli MD is an Assistant Professor of Medicine in the Division of Cardiology, College of Medicine at the University of Arkansas for Medical Sciences (UAMS) and a staff cardiologist at the Central Arkansas Veterans Health Care System(CAVHS).Dr. Vallurupalli attended medical school at the Jawaharlal Institute of Post Graduate Medical education and Research(JIPMER) in Pondicherry, India. He completed his internal medicine residency and served as a chief medical resident at the University of Illinois at Urbana Champaign. He then worked an as Assistant Professor of General Internal Medicine at the Southern Illinois University in Springfield, IL before moving to Little Rock to complete his cardiovascular diseases fellowship at UAMS. He received advanced training in echocardiography (level 3) and has special interest in the management of valvular heart disease.

Metrics

h-index: 22
Publications: 226
Citations: 2,618

Positions

Associate Professor publications 2013–2026

University of Arkansas for Medical Sciences Internal Med, College of Medicine Institutional directory
University of Arkansas for Medical Sciences publications 2013–2026

ORCID

Selected Publications

Abstract Wed134: Comparison of classic vs newer classification of Doppler wave forms of lower extremity arteries in diagnosis of obstructive peripheral arterial disease (2026)

DOI OpenAlex
GLP-1 Agonists and Risk of Atrial Fibrillation in Non-Dialysis Chronic Kidney Disease (2026)

Cardiovascular Drugs and Therapy 2 citations DOI OpenAlex
Bridging the Coverage Gap: State Medicaid Limitations for Cardiac Rehabilitation Programs and the Risk to Disadvantaged Communities (2026)

DOI OpenAlex
Characterization of Human Aortic Valve Cells isolated from Calcified Aortic Valve Replacement Explants: Implications for Calcific Aortic Valve Disease Research (2026)

DOI OpenAlex
26-A-9693-ACC PREDICTION OF 1-YEAR MAJOR ADVERSE CARDIAC EVENTS IN CAR-T RECIPIENTS USING RISK SCORE MODELING: EXPANDED WHOLE-COHORT ANALYSIS (2026)

DOI OpenAlex
26-A-11133-ACC CYTOKINE RELEASE SYNDROME-GUIDED RISK MODELS REDEFINE CARDIOTOXICITY SURVEILLANCE: OPTIMIZING DETECTION OF CANCER THERAPY-RELATED CARDIAC DYSFUNCTION AND ADVERSE CARDIOVASCULAR EVENTS AFTER CAR-T THERAPY (2026)

DOI OpenAlex
26-A-17971-ACC WHEN NORMAL ISN’T SAFE, PRESERVED PERFORMANCE, HIGHER RISK: ECHO-DERIVED FRANK-STARLING PROFILING IN POST-TIPS HEART FAILURE — PARADOXICAL ECHOCARDIOGRAPHIC PREDICTORS OF CHF READMISSION, DIURETIC ESCALATION, AND VOLUME OVERLOAD IN A PRELOAD-SENSITIVE STATE (2026)

DOI OpenAlex
26-CCC-10096-ACC CHEMOTHERAPY-INDUCED CARDIOTOXICITY VS LEFT BUNDLE BRANCH BLOCK CARDIOMYOPATHY: A DIAGNOSTIC AND MANAGEMENT CHALLENGE (2026)

DOI OpenAlex
Incidence, predictors, and pacemaker implantation rates after high-grade atrioventricular block following transcatheter tricuspid valve replacement: a real-world analysis (2026)

DOI OpenAlex
Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis (2025)

Cureus DOI OpenAlex
Late-Onset Pericardial Effusion and Device Extrusion After Left Atrial Appendage Occluder Implantation (2025)

JACC Case Reports DOI OpenAlex
Right Ventricular Outflow Tract Velocity Time Interval: An Invaluable Yet Forgotten Echocardiographic Variable (2025)

Echocardiography DOI OpenAlex
Diagnostic and prognostic utility of fractional flow reserve for in-stent restenosis (2025)

Cardiovascular revascularization medicine 2 citations DOI OpenAlex
HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE (2025)

Journal of the American College of Cardiology DOI OpenAlex
PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY (2025)

Journal of the American College of Cardiology DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

COVID-19 PREVENT (Partnership for Rapid Engagement to enhance Vaccine uptake for Everyone: Neighbors working Together) Project NIH/Nat. Heart, Lung & Blood Institute via Westat Principal Investigator